U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950462) titled 'A Phase 1 Study of QLS7402 Injection in Adult Participants With Overweight or Obesity' on Nov. 10.

Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending dose of QLS7402 injection administered subcutaneously in adult participants with overweight or obesity

Study Start Date: Jan. 13, 2027

Study Type: INTERVENTIONAL

Condition: Overweight or Obesity

Intervention: DRUG: QLS7402 Injection

QLS7402 Injection

DRUG: Placebo control

Placebo Control

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai Qilu Pharmaceutical Research and Deve...